Oncotelic与Sapu Nano发布新药代谢数据,显示静脉注射Sapu003相较于口服给药可将Everolimus的胃肠道累积减少多达67倍

美股速递
Dec 03, 2025

Oncotelic与Sapu Nano发布的新药代谢数据表明,静脉注射Sapu003相较于口服给药可将Everolimus的胃肠道累积减少多达67倍。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10